250 related articles for article (PubMed ID: 15610510)
1. Alterations of glucosylceramide-beta-glucosidase levels in the skin of patients with psoriasis vulgaris.
Alessandrini F; Pfister S; Kremmer E; Gerber JK; Ring J; Behrendt H
J Invest Dermatol; 2004 Dec; 123(6):1030-6. PubMed ID: 15610510
[TBL] [Abstract][Full Text] [Related]
2. Permeability barrier requirements regulate epidermal beta-glucocerebrosidase.
Holleran WM; Takagi Y; Menon GK; Jackson SM; Lee JM; Feingold KR; Elias PM
J Lipid Res; 1994 May; 35(5):905-12. PubMed ID: 8071612
[TBL] [Abstract][Full Text] [Related]
3. beta-Glucocerebrosidase activity in the stratum corneum of house sparrows following acclimation to high and low humidity.
Cox RM; Munoz-Garcia A; Jurkowitz MS; Williams JB
Physiol Biochem Zool; 2008; 81(1):97-105. PubMed ID: 18040976
[TBL] [Abstract][Full Text] [Related]
4. Beta-glucocerebrosidase activity in mammalian stratum corneum.
Takagi Y; Kriehuber E; Imokawa G; Elias PM; Holleran WM
J Lipid Res; 1999 May; 40(5):861-9. PubMed ID: 10224155
[TBL] [Abstract][Full Text] [Related]
5. Glucosylceramide metabolism is regulated during normal and hormonally stimulated epidermal barrier development in the rat.
Hanley K; Jiang Y; Holleran WM; Elias PM; Williams ML; Feingold KR
J Lipid Res; 1997 Mar; 38(3):576-84. PubMed ID: 9101438
[TBL] [Abstract][Full Text] [Related]
6. An accumulation of glucosylceramide in the stratum corneum due to attenuated activity of beta-glucocerebrosidase is associated with the early phase of UVB-induced alteration in cutaneous barrier function.
Takagi Y; Nakagawa H; Yaginuma T; Takema Y; Imokawa G
Arch Dermatol Res; 2005 Jul; 297(1):18-25. PubMed ID: 15912415
[TBL] [Abstract][Full Text] [Related]
7. beta-Glucocerebrosidase activity in murine epidermis: characterization and localization in relation to differentiation.
Holleran WM; Takagi Y; Imokawa G; Jackson S; Lee JM; Elias PM
J Lipid Res; 1992 Aug; 33(8):1201-9. PubMed ID: 1431599
[TBL] [Abstract][Full Text] [Related]
8. The level of prosaposin is decreased in the skin of patients with psoriasis vulgaris.
Alessandrini F; Stachowitz S; Ring J; Behrendt H
J Invest Dermatol; 2001 Mar; 116(3):394-400. PubMed ID: 11231313
[TBL] [Abstract][Full Text] [Related]
9. Expression of antiapoptotic protein c-FLIP is upregulated in psoriasis epidermis.
Yang J; Li Y; Liu YQ; Long JW; Tian F; Dong J; Shen GX; Tu YT; Tao J
Eur J Dermatol; 2009; 19(1):29-33. PubMed ID: 19059832
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of SMAD2, 4 and 6 mRNA and TGFbeta receptor I mRNA in lesional and non-lesional psoriatic skin.
Yu H; Mrowietz U; Seifert O
Acta Derm Venereol; 2009; 89(4):351-6. PubMed ID: 19688145
[TBL] [Abstract][Full Text] [Related]
11. Gromwell (Lithospermum erythrorhizon) supplementation enhances epidermal levels of ceramides, glucosylceramides, β-glucocerebrosidase, and acidic sphingomyelinase in NC/Nga mice.
Kim J; Cho Y
J Med Food; 2013 Oct; 16(10):927-33. PubMed ID: 24074295
[TBL] [Abstract][Full Text] [Related]
12. Reevaluation of the non-lesional dry skin in atopic dermatitis by acute barrier disruption: an abnormal permeability barrier homeostasis with defective processing to generate ceramide.
Sugiura A; Nomura T; Mizuno A; Imokawa G
Arch Dermatol Res; 2014 Jul; 306(5):427-40. PubMed ID: 24271939
[TBL] [Abstract][Full Text] [Related]
13. NOD-like receptor signaling and inflammasome-related pathways are highlighted in psoriatic epidermis.
Tervaniemi MH; Katayama S; Skoog T; Siitonen HA; Vuola J; Nuutila K; Sormunen R; Johnsson A; Linnarsson S; Suomela S; Kankuri E; Kere J; Elomaa O
Sci Rep; 2016 Mar; 6():22745. PubMed ID: 26976200
[TBL] [Abstract][Full Text] [Related]
14. Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2).
van der Fits L; van der Wel LI; Laman JD; Prens EP; Verschuren MC
J Pathol; 2003 Jan; 199(1):107-14. PubMed ID: 12474233
[TBL] [Abstract][Full Text] [Related]
15. Permeability barrier disruption increases the level of serine palmitoyltransferase in human epidermis.
Stachowitz S; Alessandrini F; Abeck D; Ring J; Behrendt H
J Invest Dermatol; 2002 Nov; 119(5):1048-52. PubMed ID: 12445191
[TBL] [Abstract][Full Text] [Related]
16. Expression of p53 protein in psoriasis.
Baran W; Szepietowski JC; Szybejko-Machaj G
Acta Dermatovenerol Alp Pannonica Adriat; 2005 Sep; 14(3):79-83. PubMed ID: 16200332
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin.
Johansen C; Usher PA; Kjellerup RB; Lundsgaard D; Iversen L; Kragballe K
Br J Dermatol; 2009 Feb; 160(2):319-24. PubMed ID: 19016708
[TBL] [Abstract][Full Text] [Related]
18. The proteasome maturation protein POMP increases proteasome assembly and activity in psoriatic lesional skin.
Zieba BA; Henry L; Lacroix M; Jemaà M; Lavabre-Bertrand T; Meunier L; Coux O; Stoebner PE
J Dermatol Sci; 2017 Oct; 88(1):10-19. PubMed ID: 28728908
[TBL] [Abstract][Full Text] [Related]
19. Sustained serine proteases activity by prolonged increase in pH leads to degradation of lipid processing enzymes and profound alterations of barrier function and stratum corneum integrity.
Hachem JP; Man MQ; Crumrine D; Uchida Y; Brown BE; Rogiers V; Roseeuw D; Feingold KR; Elias PM
J Invest Dermatol; 2005 Sep; 125(3):510-20. PubMed ID: 16117792
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of tumour necrosis factor-alpha-converting enzyme in psoriasis.
Kawaguchi M; Mitsuhashi Y; Kondo S
Br J Dermatol; 2005 May; 152(5):915-9. PubMed ID: 15888146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
